2.94
price down icon2.65%   -0.08
after-market Handel nachbörslich: 2.94
loading

Finanzdaten der Bone Biologics Corp-Aktie (BBLG)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - -
Operating Expenses
22.11%
0.9035
1.16 2.0809 3.0399 3.1475
Provision For Loan, Lease, And Other Losses
-
- - - -
Operating Income/Loss
22.11%
-0.9035
-1.16 -2.0809 -3.0399 -3.1475
Net Interest Income/Expense
0.000255
- - - -
Nonoperating Income/Loss
0.0376
- - - -
Income/Loss From Continuing Operations Before Tax
44.13%
-0.866
-1.5499 -1.9197 -1.7692 -3.7099
Income/Loss From Continuing Operations After Tax
44.13%
-0.866
-1.5499 -1.9197 -1.7692 -3.7099
Net Income/Loss
44.13%
-0.866
-1.5499 -1.9197 -1.7692 -3.7099
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
150.10%
0.6609
-1.3193 3.1344 1.047 16.12
Diluted Average Shares
150.10%
0.6609
-1.3193 3.1344 1.047 -0.2535
Basic Earnings Per Share
95.53%
-1.31
-29.33 -0.61 -1.69 -0.23
Diluted Earnings Per Share
95.53%
-1.31
-29.33 -0.61 -1.69 -5.21
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$289.32
price down icon 2.72%
medical_devices PHG
$24.03
price down icon 2.55%
medical_devices STE
$228.03
price down icon 1.17%
$83.37
price down icon 2.45%
$75.13
price down icon 1.79%
medical_devices EW
$78.05
price down icon 0.95%
Kapitalisierung:     |  Volumen (24h):